GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Net Income From Continuing Operations

Kimia Biosciences (BOM:530313) Net Income From Continuing Operations : ₹0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Kimia Biosciences's net income from continuing operations for the six months ended in . 20 was ₹0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.

Kimia Biosciences Net Income From Continuing Operations Historical Data

The historical data trend for Kimia Biosciences's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Net Income From Continuing Operations Chart

Kimia Biosciences Annual Data
Trend
Net Income From Continuing Operations

Kimia Biosciences Semi-Annual Data
Net Income From Continuing Operations

Kimia Biosciences Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kimia Biosciences (BOM:530313) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:531739 BOM:532384 BOM:532989 BOM:540686 BOM:532637 BOM:531173 BOM:531726 BOM:532878 BOM:524518 BOM:537536 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Website
https://www.kimiabiosciences.com
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines